C1GALT1 | Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf109 | Chromosome 1 open reading frame 109 | Predicted intracellular proteins
| | | | | Expressed in all |
C1orf116 | Chromosome 1 open reading frame 116 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf131 | Chromosome 1 open reading frame 131 | Predicted intracellular proteins
| | | | | Expressed in all |
C1QA | Complement component 1, q subcomponent, A chain | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
C21orf2 | Chromosome 21 open reading frame 2 | Predicted intracellular proteins
| | | | | Expressed in all |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C21orf59 | Chromosome 21 open reading frame 59 | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
C2CD2 | C2 calcium-dependent domain containing 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C6orf211 | Chromosome 6 open reading frame 211 | Predicted intracellular proteins
| | | | | Expressed in all |
C6orf62 | Chromosome 6 open reading frame 62 | Predicted intracellular proteins
| | | | | Expressed in all |
C8B | Complement component 8, beta polypeptide | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C9orf78 | Chromosome 9 open reading frame 78 | Predicted intracellular proteins
| | | | | Expressed in all |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CA10 | Carbonic anhydrase X | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CA12 | Carbonic anhydrase XII | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAB39 | Calcium binding protein 39 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CABS1 | Calcium-binding protein, spermatid-specific 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
CACNA1S | Calcium channel, voltage-dependent, L type, alpha 1S subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
CACTIN | Cactin, spliceosome C complex subunit | Predicted intracellular proteins
| | | | | Expressed in all |
CADPS | Ca++-dependent secretion activator | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CALB1 | Calbindin 1, 28kDa | Predicted intracellular proteins
| | | | | Tissue enriched |
CALCOCO2 | Calcium binding and coiled-coil domain 2 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Expressed in all |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CALML5 | Calmodulin-like 5 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CALU | Calumenin | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPG | Capping protein (actin filament), gelsolin-like | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CARD8 | Caspase recruitment domain family, member 8 | Predicted intracellular proteins
| | | | | Expressed in all |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CASC4 | Cancer susceptibility candidate 4 | Predicted intracellular proteins
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CASKIN1 | CASK interacting protein 1 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CASP14 | Caspase 14, apoptosis-related cysteine peptidase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
CASQ2 | Calsequestrin 2 (cardiac muscle) | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |